These are the kind of shares I love. I've already bought into TSCO and AV based on their beaten-down (or is it beaten-up?) share price.
I wouldn't touch AZ though, because of their poor pipeline, with little that I can see in the way of a strategy to improve it. And anybody who knows anything about Pharma companies will realise that it takes years to develop a sustainable pipeline. I'm more than happy to stick with my holding in GSK for that reason
